Nano-X Imaging Receives FDA Clearance for Nanox.ARC X-ray System

MT Newswires Live2024-12-05

Nano-X Imaging (NNOX) said Thursday it received 510(k) clearance from the U.S. Food and Drug Administration for its Nanox.ARC stationary X-ray system.

The Nanox.ARC system is designed to produce tomographic images for general use, complementing conventional radiography, on adults. The system uses a proprietary digital X-ray source and advanced tomosynthesis technology with a cold cathode to generate 3D images.

The company said the clearance will help broaden Nanox.ARC's commercial expansion in the U.S., which is currently deployed in healthcare facilities across seven U.S. states, and with "a few dozen units in various stages of shipments and deployments" for commercial and clinical uses worldwide.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment